2019 has brought another contribution from the Immunoassay Center (CIE) to Cuban health services, with the incorporation of the diagnostic for neonatal TIR (immunoreactive trypsinogen), for the screening of cystic fibrosis in newborns.
The product of the Suma technology, developed by CIE professionals, makes it possible to identify the protein produced by the pancreas that is related to this condition, so that up to June of this year 37,746 newborns have been studied.
With this diagnostician there are already six diseases that are researched in Cuban newborns, thanks to the products of the Immunoassay Center: congenital hypothyroidism, phenylketonuria, biotinidase deficit, congenital adrenal hyperplasia, galactosemia and cystic fibrosis; which joins many other contributions of this institution, which constitutes a cornerstone in the prevention, diagnosis and treatment of diseases.
The CIE's mission is to guarantee the strategies, technologies and reactives necessary for the integral active investigation of the main causes of morbidity in the Cuban population, and in its list of relevant results during its 32 years - it was founded on September 7, 1987 by Commander in Chief Fidel Castro Ruz - the Suma technology stands out, one hundred percent Cuban and developed by this institution.
Suma is "the technological base of important health programs of the Ministry of Public Health, from which all our people benefit from before birth to the last stages of life," specialist Rebeca Sonia Gonzalez Fernandez, communicator of the center, explained to Granma.
Cuba was the second country in the world with a complete program of alpha-fetoprotein, also a product of the CIE, for the detection of malformations in the closure of the neural tube, recalled the interviewed woman, who highlighted that from 1982 to 2018 this has allowed four million 705 thousand 240 pregnant women to be investigated and more than nine thousand malformations to be detected.
The diagnosticians for congenital adrenal hyperplasia, for the study of pregnant women and their partners in the search for HIV; for prostate cancer; Sumasohf, for colon cancer research, and to detect proteins in the urine, which reveal chronic renal disease, among others, are added to the contributions of this important scientific center.
In addition, they are responsible for the technology that is present in 100 percent of the consultations of neck pathology and other municipal consultations of benign pathologies throughout the country; they produce glucometers and biosensors for the control of people with diabetes, electrosurgery equipment for the operating rooms and spectrophotometers vs 850 needed in clinical laboratories.
With information from Granma
Comments (0)